MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with C

Co-amilofruse

Co-amilofruse 2.5mg/20mg tablets

No stability information

Stability notes for Co-amilofruse 2.5mg/20mg tablets

There are no stability notes for this medicine.

Suppliers (9) of Co-amilofruse 2.5mg/20mg tablets
Co-amilofruse 2.5mg/20mg tablets (A A H Pharmaceuticals Ltd)
Co-amilofruse 2.5mg/20mg tablets (Alliance Healthcare (Distribution) Ltd)
Co-amilofruse 2.5mg/20mg tablets (Ennogen Healthcare International Ltd)
Co-amilofruse 2.5mg/20mg tablets (Medihealth (Northern) Ltd)
Co-amilofruse 2.5mg/20mg tablets (Milpharm Ltd)
Co-amilofruse 2.5mg/20mg tablets (Phoenix Healthcare Distribution Ltd)
Co-amilofruse 2.5mg/20mg tablets (Sigma Pharmaceuticals Plc)
Co-amilofruse 2.5mg/20mg tablets (Wockhardt UK Ltd)
Frumil LS 20mg/2.5mg tablets (Necessity Supplies Ltd)

Co-amilofruse 5mg/40mg tablets

No stability information

Stability notes for Co-amilofruse 5mg/40mg tablets

There are no stability notes for this medicine.

Suppliers (13) of Co-amilofruse 5mg/40mg tablets
Co-amilofruse 5mg/40mg tablets (A A H Pharmaceuticals Ltd)
Co-amilofruse 5mg/40mg tablets (Alliance Healthcare (Distribution) Ltd)
Co-amilofruse 5mg/40mg tablets (CST Pharma Ltd)
Co-amilofruse 5mg/40mg tablets (Ennogen Healthcare International Ltd)
Co-amilofruse 5mg/40mg tablets (Medihealth (Northern) Ltd)
Co-amilofruse 5mg/40mg tablets (Milpharm Ltd)
Co-amilofruse 5mg/40mg tablets (Phoenix Healthcare Distribution Ltd)
Co-amilofruse 5mg/40mg tablets (Sigma Pharmaceuticals Plc)
Co-amilofruse 5mg/40mg tablets (Wockhardt UK Ltd)
Frumil 40mg/5mg tablets (CST Pharma Ltd)
Frumil 40mg/5mg tablets (Lexon (UK) Ltd)
Frumil 40mg/5mg tablets (Necessity Supplies Ltd)
Frumil 40mg/5mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.